Tumor cells-specific targeting delivery achieved by A54 peptide functionalized polymeric micelles

Biomaterials

Volumn 33, Issue 34, 2012, Pages 8858-8867

  Du, Yong Zhong ^a   Cai, Li Li ^a   Liu, Ping ^a   You, Jian ^a   Yuan, Hong ^a   Hu, Fu Qiang ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Active targeting; Anti tumor activity; Homing peptide; Poly(ethylene glycol); Stearic acid grafted chitosan

Indexed keywords

ACTIVE TARGETING; ADRIAMYCIN; ANTI-TUMOR ACTIVITIES; CURATIVE EFFECTS; DELIVERY SYSTEMS; DOXORUBICIN; ENHANCED PERMEABILITY AND RETENTIONS; FUNCTIONALIZED; HOMING PEPTIDE; HUMAN HEPATOMA CELLS; IN-VITRO; IN-VIVO; LIVER CELLS; MICELLES LOADING; PASSIVE TARGETING; PEPTIDE LIBRARY; PHAGE-DISPLAY; POLYMERIC MICELLE; REDUCED TOXICITY; SIDE EFFECT; TUMOR CELLS; TUMOR GROWTH; TUMOR TARGETING;

CHITOSAN; LOADING; MICELLES; PEPTIDES; POLYETHYLENE OXIDES; STEARIC ACID; TUMORS;

POLYETHYLENE GLYCOLS;

A54 PEPTIDE; CHITOSAN; DOXORUBICIN; DRUG CARRIER; MACROGOL; STEARIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG DISTRIBUTION; HEPATOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CHITOSAN; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; LIVER; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICELLES; OLIGOPEPTIDES; POLYETHYLENE GLYCOLS; RATS; STEARIC ACIDS;

EID: 84866851754     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.08.043     Document Type: Article

References (42)

1. Du B., Han H., Wang Z., Kuang L., Wang L., Yu L., et al. Targeted drug delivery to hepatocarcinoma in vivo by phage-displayed specific binding peptide. Mol Cancer Res 2010, 8:135-144.
2. Watts R.G., George M.K., Johnson W.H. Pretreatment and routine echocardiogram monitoring during chemotherapy for anthracycline-induced cardiotoxicity rarely identifies significant cardiac dysfunction or alters treatment decisions. Cancer 2011, 18:1919-1924.
3. Mastrobattista E., Koning G.A., Storm G. Immunoliposomes for the targeted delivery of antitumor drugs. Adv Drug Deliv Rev 1999, 40:103-127.
4. Duncan R. Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer 2006, 6:688-701.
5. Scott A.W., Tyler B.M., Masi B.C., Upadhyay U.M., Patta Y.R., Grossman R., et al. Intracranial microcapsule drug delivery device for the treatment of an experimental gliosarcoma model. Biomaterials 2011, 32:2532-2539.
6. Vila A., Sanchez A., Tobi'O M., Calvo P., Alonso M.J. Design of biodegradable particles for protein delivery. J Control Release 2002, 78:15-24.
7. Liu Y., Huang R., Han L., Ke W., Shao K., Ye L., et al. Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles. Biomaterials 2009, 30:4195-4202.
8. Maeda H., Wu J., Sawa T., Matsumura Y., Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 2000, 65:271-284.
9. Danquah M.K., Zhang X.A., Mahato R.I. Extravasation of polymeric nanomedicines across tumor vasculature. Adv Drug Deliv Rev 2010, 63:623-639.
10. Greenwald R.B. PEG drugs: an overview. J Control Release 2001, 74:159-171.
11. Torchilin V.P., Trubetskoy V.S. Which polymers can make nanoparticulate drug carriers long-circulating?. Adv Drug Deliv Rev 1995, 16:141-155.
12. Inada Y., Furukawa M., Sasaki H., Kodera Y., Hiroto M., Nishimura H., et al. Biomedical and biotechnological applications of PEG-and PM-modified proteins. Trends Biotechnol 1995, 13:86-91.
13. Shibata H., Yoshioka Y., Ikemizu S., Kobayashi K., Yamamoto Y., Mukai Y., et al. Functionalization of tumor necrosis factor-α using phage display technique and PEGylation improves its antitumor therapeutic window. Clin Cancer Res 2004, 10:8293-8300.
14. Terada T., Mizobata M., Kawakami S., Yamashita F., Hashida M. Optimization of tumor-selective targeting by basic fibroblast growth factor-binding peptide grafted PEGylated liposomes. J Control Release 2007, 119:262-270.
15. Allen T.M. The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system. Adv Drug Deliv Rev 1994, 13:285-309.
16. Verrecchia T., Spenlehauer G., Bazile D.V., Murry-Brelier A., Archimbaud Y., Veillard M. Non-stealth (poly(lactic acid/albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriers. J Control Release 1995, 36:49-61.
17. Hong J.W., Park J.H., Huh K.M., Chung H., Kwon I.C., Jeong S.Y. PEGylated polyethylenimine for in vivo local gene delivery based on lipiodolized emulsion system. J Control Release 2004, 99:167-176.
18. Wang Y., Ke C.Y., Weijie Beh C., Liu S.Q., Goh S.H., Yang Y.Y. The self-assembly of biodegradable cationic polymer micelles as vectors for gene transfection. Biomaterials 2007, 28:5358-5368.
19. Conner S.D., Schmid S.L. Regulated portals of entry into the cell. Nature 2003, 422:37-44.
20. Pasqualini R., Ruoslahti E. Organ targeting in vivo using phage display peptide libraries. Nature 1996, 380:364-366.
21. Aina O.H., Sroka T.C., Chen M.L., Lam K.S. Therapeutic cancer targeting peptides. Biopolymers 2002, 66:184-199.
22. Lo S.L., Wang S. An endosomolytic Tat peptide produced by incorporation of histidine and cysteine residues as a nonviral vector for DNA transfection. Biomaterials 2008, 29:2408-2414.
23. You J., Hu F.Q., Du Y.Z., Yuan H. Polymeric micelles with glycolipid-like structure and multiple hydrophobic domains for mediating molecular target delivery of paclitaxel. Biomacromolecules 2007, 8:2450-2456.
24. Hu F.Q., Meng P., Dai Y.Q., Du Y.Z., You J., Wei X.H., et al. PEGylated chitosan-based polymer micelle as an intracellular delivery carrier for anti-tumor targeting therapy. Eur J Pharm Biopharm 2008, 70:749-757.
25. Hu F.Q., Zhao M.D., Yuan H., You J., Du Y.Z., Zeng S. A novel chitosan oligosaccharide-stearic acid micelles for gene delivery: properties and in vitro transfection studies. Int J Pharm 2006, 315:158-166.
26. Lee K.Y., Kwon I.C., Kim Y.H., Jo W.H., Jeong S.Y. Preparation of chitosan self-aggregates as a gene delivery system. J Control Release 1998, 51:213-220.
27. Martina M.S., Wilhelm C., Lesieur S. The effect of magnetic targeting on the uptake of magnetic-fluid-loaded liposomes by human prostatic adenocarcinoma cells. Biomaterials 2008, 29:4137-4145.
28. Hu F.Q., Liu L.N., Du Y.Z., Yuan H. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles. Biomaterials 2009, 30:6955-6963.
29. Grabarek Z., Gergely J. Zero-length crosslinking procedure with the use of active esters. Anal Biochem 1990, 185:131-135.
30. Boden N., Bushby R.J., Liu Q., Evans S.D., Jenkins A.T.A., Knowles P.F., et al. N,N'-Disuccinimidyl carbonate as a coupling agent in the synthesis of thiophospholipids used for anchoring biomembranes to gold surfaces. Tetrahedron 1998, 54:11537-11548.
31. Gao Z., Eisenberg A. A model of micellization for block copolymers in solutions. Macromolecules 1993, 26:7353-7360.
32. Cabral H., Matsumoto Y., Mizuno K., Chen Q., Murakami M., Kimura M., et al. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat Biotechnol 2011, 6:815-823.
33. Jain R.K. Delivery of molecular and cellular medicine to solid tumors. J Control Release 1998, 53:49-67.
34. You J., Li X., Cui F.D., Du Y.Z., Yuan H. Folate-conjugated polymer micelles for active targeting to cancer cells: preparation, in vitro evaluation of targeting ability and cytotoxicity. Nanotechnology 2008, 19:45102.
35. Eliyahu H., Joseph A., Schillemans J.P., Azzam T., Domb A.J., Barenholz Y. Characterization and in vivo performance of dextran-spermine polyplexes and DOTAP/cholesterol lipoplexes administered locally and systemically. Biomaterials 2007, 28:2339-2349.
36. Wu L., Zhang J., Watanabe W. Physical and chemical stability of drug nanoparticles. Adv Drug Deliv Rev 2011, 63:456-469.
37. Liu S.Y., Liang Z.S., Gao F., Luo S.F., Lu G.Q. In vitro photothermal study of gold nanoshells functionalized with small targeting peptides to liver cancer cells. J Mater Sci Mater Med 2010, 21:665-674.
38. Jiang J.S., Gan Z.F., Yang Y., Du B., Qian M., Zhang P. A novel magnetic fluid based on starch-coated magnetite nanoparticles functionalized with homing peptide. J Nanoparticle Res 2009, 11:1321-1330.
39. Yang Y., Jiang S.J., Du B., Gan Z.F., Qian M., Zhang P. Preparation and properties of a novel drug delivery system with both magnetic and biomolecular targeting. J Mater Sci Mater Med 2009, 20:301-307.
40. Loo C., Lowery A., Halas N., West J., Drezek R. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett 2005, 5:709-711.
41. Ntziachristos V., Bremer C., Weissleder R. Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol 2003, 13:195-208.
42. Gao X., Cui Y., Levenson R.M., Chung L.W.K., Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004, 22:969-976.